0001209191-21-036664.txt : 20210528 0001209191-21-036664.hdr.sgml : 20210528 20210528185006 ACCESSION NUMBER: 0001209191-21-036664 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Dowd Sarah A CENTRAL INDEX KEY: 0001447149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 21982246 MAIL ADDRESS: STREET 1: 3185 LAURELVIEW COURT CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-27 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001447149 O'Dowd Sarah A C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BOULEVARD, SUITE 140 NEWARK CA 94560 1 0 0 0 Stock Option (right to buy) 35.23 2021-05-27 4 A 0 18000 0.00 A 2031-05-26 Common Stock 18000 18000 D The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). /s/ Donald Kalkofen, Attorney-in-Fact for Sarah A. O'Dowd 2021-05-28